San Francisco Bay Area biotech stories.
Wednesday, May 16, 2012
Avalanche Bio inks manufacturing technology deal with Lonza
Startup Avalanche Biotechnologies Inc. and biologics manufacturer Lonza Group Ltd. inked a deal
that will help Avalanche -- and possibly other companies -- produce drugs for clinical trials and more. Financial terms of the manufacturing deal weren't disclosed. San Francisco-based Avalanche said the collaboration will focus on process development and scale-up efforts for making adeno-associated viral vectors for gene therapy.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)